Login to Your Account

Launch Of Europe's First Biogeneric Drug Imminent

By Cormac Sheridan

Wednesday, April 19, 2006
Sandoz GmbH plans to launch Europe's first biogeneric drug, Omnitrope (somatropin), within a matter of days, following the European Commission's decision Tuesday to grant a marketing authorization for the recombinant human growth hormone. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription